Getinge Group subsidiary Maquet restructured the organization of its U.S. sales and services to meet the growing hybrid operating room market.
Hybrid OR’s contain both a traditional operating room and a cardiac catheterization lab, minimizing the need to move a sick patient from room to room for complex procedures.
The suites are designed to foster collaboration between cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons and build a more efficient workflow.
The combined ORs are expected to lead to significant savings in health care spending by improving the patient outcomes after surgery and shortening the length of hospital stays, according to the company.
In late September, Maquet’s Sensation Plus aortic balloon catheter won FDA approval and CE Mark clearance in the European Union.
Maquet’s parent company, Sweden-based Getinge Group, announced a definitive agreement in October to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton.